Opium consumption and coronary atherosclerosis in diabetic patients: A propensity score-matched study

Planta Medica

Volumn 77, Issue 17, 2011, Pages 1870-1875

  Hosseini, Seyed Kianoosh ^a   Masoudkabir, Farzad ^b   Vasheghani Farahani, Ali ^a   Alipour Parsa, Saeed ^c   Sheikh Fathollahi, Mahmood ^a   Rahimi Foroushani, Abbas ^b   Hakki, Elham ^a   Goodarzynejad, Hamidreza ^a   Eftekhar, Hassan ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

atherosclerosis; diabetes mellitus; opium; Papaver somniferum; Papaveraceae

Indexed keywords

OPIATE;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DISEASE SEVERITY; DRUG DOSAGE FORM COMPARISON; DRUG USE; EXTENT SCORE; FEMALE; GENDER; GENSINI SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; SMOKING;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; AGED; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; OPIUM; PAPAVER; PROPENSITY SCORE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; TIME FACTORS;

PAPAVER SOMNIFERUM; PAPAVERACEAE;

EID: 82155173536     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0031-1280017     Document Type: Article

References (34)

1. Colagiuri R. Diabetes: a pandemic, a development issue or both? Expert Rev Cardiovasc Ther 2010 8 305-309
2. Prevention of diabetes mellitus. Report of a WHO study group. World Health Organ Tech Rep Ser 1994 844 1-100
3. Kulsudjarit K. Drug problem in southeast and southwest Asia. Ann NY Acad Sci 2004 1025 446-457 (Pubitemid 39643893)
4. Karbakhsh M, Salehian Zandi N. Acute opiate overdose in Tehran: the forgotten role of opium. Addict Behav 2007 32 1835-1842 (Pubitemid 47031484)
5. Mohammadi A, Darabi M, Nasry M, Saabet-Jahromi M J., Malek-Pour-Afshar R, Sheibani H. Effect of opium addiction on lipid profile and atherosclerosis formation in hypercholesterolemic rabbits. Exp Toxicol Pathol 2009 61 145-149
6. Karam G A., Reisi M, Kaseb A A., Khaksari M, Mohammadi A, Mahmoodi M. Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus. Addict Biol 2004 9 53-58 (Pubitemid 38608486)
7. Sadr Bafghi S M., Rafiei M, Bahadorzadeh L, Namayandeh S M., Soltani M H., Motafaker M, Andishmand A. Is opium addiction a risk factor for acute myocardial infarction? Acta Med Iran 2005 43 218-222 (Pubitemid 41414811)
8. Farahani M A., Mohammadi E, Ahmadi F, Maleki M, Hajizadeh E. Cultural barriers in the education of cardiovascular disease patients in Iran. Int Nurs Rev 2008 55 360-366
9. Marmor M, Penn A, Widmer K, Levin R I., Maslansky R. Coronary artery disease and opioid use. Am J Cardiol 2004 93 1295-1297 (Pubitemid 38595689)
10. Azimzade-Sarwar B, Yousefzade G, Narooey S. A case-control study of effect of opium addiction on myocardial infarction. Am J Appl Sci 2005 2 1134-1135
11. Davoodi G, Sadeghian S, Akhondzadeh S, Darvish S, Alidoosti M, Amirzadegan A. Comparison of specifications, short-term outcome and prognosis of acute myocardial infarction in opium dependent patients and non-dependents. Ger J Psych 2005 8 33-37 (Pubitemid 41410188)
12. Sadeghian S, Darvish S, Davoodi G, Salarifar M, Mahmoodian M, Fallah N, Karimi A A. The association of opium with coronary artery disease. Eur J Cardiovasc Prev Rehabil 2007 14 715-717 (Pubitemid 47556410)
13. Joukar S, Najafipour H, Malekpour-Afshar R, Mirzaeipour F, Nasri H R. The effect of passive opium smoking on cardiovascular indices of rabbits with normal and ischemic hearts. Open Cardiovasc Med J 2010 4 1-6
14. Najafipour H, Joukar S, Malekpour-Afshar R, Mirzaeipour F, Nasri H R. Passive opium smoking does not have beneficial effect on plasma lipids and cardiovascular indices in hypercholesterolemic rabbits with ischemic and non-ischemic hearts. J Ethnopharmacol 2010 127 257-263
15. Chobanian A V., Bakris G L., Black H R., Cushman W C., Green L A., Izzo jr. J L., Jones D W., Materson B J., Oparil S, Wright jr. J T., Roccella E J. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 42 1206-1252 (Pubitemid 37553153)
16. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001 285 2486-2497
17. Hubert H B., Holford T R., Kannel W B. Clinical characteristics and cigarette smoking in relation to prognosis of angina pectoris in Framingham. Am J Epidemiol 1982 115 231-242 (Pubitemid 12182302)
18. Hopkins P N., Williams R R. Human genetics and coronary heart disease: a public health perspective. Annu Rev Nutr 1989 9 303-345
19. Gensini G G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983 51 606 (Pubitemid 13187192)
20. Negri M, Sheiban I, Arigliano P L., Tonni S, Montresor G, Carlini S, Manzato F. Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin, C-peptide, and plasminogen activator inhibitor-1. Am J Cardiol 1993 72 397-401 (Pubitemid 23238421)
21. Birnie D H., Holme E R., Mckay I C., Hood S, Mccoll K E., Hillis W S. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J 1998 19 387-394 (Pubitemid 28120718)
22. Oberman A, Jones W B., Riley C, Reeves T J., Sheffield L T., Turner M E. Natural history of coronary artery disease. Bull NY Acad Med 1972 48 1109-1125
23. Rosenbaum P R. Observational studies. 2nd edition. New York Springer-Verlag 2002
24. D'Agostino jr. R B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998 17 2265-2281 (Pubitemid 28466823)
25. Phillips G B., Pinkernell B H., Jing T Y. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb 1994 14 701-706
26. Asgary S, Sarrafzadegan N, Naderi G A., Rozbehani R. Effect of opium addiction on new and traditional cardiovascular risk factors: do duration of addiction and route of administration matter? Lipids Health Dis 2008 7 42
27. George S, Murali V, Pullickal R. Review of neuroendocrine correlates of chronic opiate misuse. Addict Disord Their Treatment 2005 4 99-109
28. Sheldon B H., Quin J D. Diabetes and illicit drug use. Practical Diabetes Int 2005 2005 222-224 (Pubitemid 46992860)
29. Moshtaghi-Kashanian G R., Esmaeeli F, Dabiri S. Enhanced prolactin levels in opium smokers. Addict Biol 2006 10 345-349
30. Sauro M D., Zorn N E. Prolactin induces proliferation of vascular smooth muscle cells through a protein kinase C-dependent mechanism. J Cell Physiol 1991 148 133-138 (Pubitemid 21910135)
31. Singh S K., Suresh M V., Voleti B, Agrawal A. The connection between C-reactive protein and atherosclerosis. Ann Med 2008 40 110-120 (Pubitemid 351640645)
32. Danesh J, Lewington S, Thompson S G., Lowe G D., Collins R, Kostis J B., Wilson A C., Folsom A R., Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell J W., Sweetnam P M., Elwood P C., Cushman M, Psaty B M., Tracy R P., Tybjaerg-Hansen A, Haverkate F, De Maat M P., Fowkes F G., Lee A J., Smith F B., Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D'agostino R, Kannel W B., Wilson P W., Tofler G, Arocha-Pinango C L., Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald M P., Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb J D., Rodriguez B, Yano K, Salonen J T., Nyyssonen K, Tuomainen T P., Hedblad B, Lind P, Loewel H, Koenig W, Meade T W., Cooper J A., De Stavola B, Knottenbelt C, Miller G J., Bauer K A., Rosenberg R D., Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans A E., Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Despres J P., Dagenais G R., Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh J L., Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Ford I, Robertson M, Brunner E, Shipley M, Feskens E J., Kromhout D, Dickinson A, Ireland B, Juzwishin K, Kaptoge S, Memon A, Sarwar N, Walker M, Wheeler J, White I, Wood A. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005 294 1799-1809 (Pubitemid 41434626)
33. Schmidt C, Fagerberg B. ApoB/apoAI ratio is related to femoral artery plaques in 64-year-old women also in cases with low LDL cholesterol. Atherosclerosis 2008 196 817-822
34. Azod L, Rashidi M, Afkhami-Ardekani M, Kiani G, Khoshkam F. Effect of opium addiction on diabetes. Am J Drug Alcohol Abuse 2008 34 383-388 (Pubitemid 351913738)